Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Total Liabilities (2016 - 2020)

Historic Total Liabilities for Larimar Therapeutics (LRMR) over the last 8 years, with Q3 2020 value amounting to $11.3 million.

  • Larimar Therapeutics' Total Liabilities fell 6571.64% to $11.3 million in Q3 2020 from the same period last year, while for Sep 2020 it was $11.3 million, marking a year-over-year decrease of 6571.64%. This contributed to the annual value of $5.9 million for FY2019, which is 7930.93% down from last year.
  • As of Q3 2020, Larimar Therapeutics' Total Liabilities stood at $11.3 million, which was down 6571.64% from $12.9 million recorded in Q2 2020.
  • In the past 5 years, Larimar Therapeutics' Total Liabilities ranged from a high of $33.0 million in Q3 2019 and a low of $5.9 million during Q4 2019
  • For the 5-year period, Larimar Therapeutics' Total Liabilities averaged around $19.0 million, with its median value being $15.6 million (2016).
  • As far as peak fluctuations go, Larimar Therapeutics' Total Liabilities soared by 29818.03% in 2018, and later plummeted by 7930.93% in 2019.
  • Over the past 5 years, Larimar Therapeutics' Total Liabilities (Quarter) stood at $9.9 million in 2016, then skyrocketed by 175.85% to $27.3 million in 2017, then rose by 4.39% to $28.5 million in 2018, then tumbled by 79.31% to $5.9 million in 2019, then surged by 91.96% to $11.3 million in 2020.
  • Its Total Liabilities stands at $11.3 million for Q3 2020, versus $12.9 million for Q2 2020 and $23.0 million for Q1 2020.